Results     25-May-16
Announcements
Astrazeneca Pharma India standalone net profit declines 98.53% in the March 2016 quarter
Sales rise 10.52% to Rs 133.51 crore
Net profit of Astrazeneca Pharma India declined 98.53% to Rs 0.56 crore in the quarter ended March 2016 as against Rs 38.13 crore during the previous quarter ended March 2015. Sales rose 10.52% to Rs 133.51 crore in the quarter ended March 2016 as against Rs 120.80 crore during the previous quarter ended March 2015.

For the full year,net profit reported to Rs 5.26 crore in the year ended March 2016 as against net loss of Rs 20.84 crore during the previous year ended March 2015. Sales rose 12.24% to Rs 526.46 crore in the year ended March 2016 as against Rs 469.05 crore during the previous year ended March 2015.

ParticularsQuarter EndedYear Ended
 Mar. 2016Mar. 2015% Var.Mar. 2016Mar. 2015% Var.
Sales133.51120.80 11 526.46469.05 12
OPM %2.4033.77 -3.12-2.43 -
PBDT5.3042.15 -87 23.19-5.56 LP
PBT1.0638.13 -97 5.76-20.84 LP
NP0.5638.13 -99 5.26-20.84 LP

Previous News
  AstraZeneca Pharma gets DCGI nod for breast cancer drug
 ( Hot Pursuit - 22-Aug-22   11:11 )
  Astrazeneca Pharma rises on planning to launch Enhertu
 ( Hot Pursuit - 21-Dec-23   10:01 )
  Astrazeneca Pharma India standalone net profit rises 236.78% in the June 2019 quarter
 ( Results - Announcements 07-Aug-19   16:27 )
  Astrazeneca Pharma India to hold board meeting
 ( Corporate News - 31-Jan-23   12:07 )
  AstraZeneca Pharma India terminates its distribution agreement with Abbott Healthcare
 ( Corporate News - 28-May-21   12:00 )
  Astrazeneca Pharma India to launch Osimertinib Tablets (Tagrisso™)
 ( Corporate News - 22-Jul-17   10:02 )
  Astrazeneca Pharma gets nod from CDSCO to import Olaparib film coated tablets
 ( Hot Pursuit - 22-Nov-23   11:07 )
  AstraZeneca Pharma India terminates distribution services agreement with Sun Pharma
 ( Corporate News - 28-May-21   12:47 )
  Astrazeneca Pharma India standalone net profit rises 10.17% in the June 2018 quarter
 ( Results - Announcements 15-Aug-18   13:44 )
  Astrazeneca Pharma India receives Import and Market permission for Osimertinib Tablet
 ( Corporate News - 09-Aug-18   10:47 )
  Astrazeneca Pharma India reports standalone net loss of Rs 27.96 crore in the September 2014 quarter
 ( Results - Announcements 04-Nov-14   08:42 )
Other Stories
  Atlas Cycles (Haryana) reports standalone net loss of Rs 0.46 crore in the June 2024 quarter
  06-Jul-24   07:32
  Emerald Finance consolidated net profit rises 98.84% in the June 2024 quarter
  05-Jul-24   15:52
  Kronox Lab Sciences standalone net profit rises 140.98% in the March 2024 quarter
  29-Jun-24   07:31
  Performance Chemiserve standalone net profit rises 6062.22% in the March 2024 quarter
  27-Jun-24   07:24
  Sundew Properties standalone net profit rises 119.15% in the March 2024 quarter
  27-Jun-24   07:24
  IKF Home Finance standalone net profit rises 42.15% in the March 2024 quarter
  27-Jun-24   07:24
  Delhi Transco standalone net profit rises 1.08% in the March 2024 quarter
  27-Jun-24   07:24
  Profectus Capital Pvt standalone net profit rises 12.12% in the March 2024 quarter
  27-Jun-24   07:24
  Shrem Infra Invest Pvt consolidated net profit rises 290.12% in the March 2024 quarter
  27-Jun-24   07:24
  Bharat Ekansh reports consolidated net loss of Rs 0.01 crore in the March 2024 quarter
  27-Jun-24   07:24
Back Top